IMA CIK: 1835579

ImageneBio, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−60.3
FY22:
−74.1
FY23:
−79.7
FY24:
−21.3
FY25:
−47.8
Change from FY21 to FY25
millions USD
FY21:
−1.76
FY22:
−99.3
FY23:
64.1
FY24:
11.1
FY25:
−5.81
Change from FY21 to FY25
millions USD
FY21:
132
FY22:
1.10
FY23:
76.0
FY24:
6.91
FY25:
135
millions USD
FY21:
–
FY22:
–
FY23:
–
FY24:
−3.20
FY25:
82.4
(positive)
Change from FY21 to FY23
millions USD
FY21:
−62.0
FY22:
−75.5
FY23:
−80.2
FY24:
–
FY25:
–

All amounts in millions USD Data source:SEC EDGAR